Under the Falsified Medicines Directive (FMD) Delegated Regulation (EU2016/161), all new packs of prescription medicines put on the market from 9th February 2019 will have two safety features:
A unique identifier or 'UI' (a 2D data matrix code and human readable information) which will be placed on medical products that can be scanned at fixed points along the supply chain
Tamper evident features (anti-tampering device or 'ATD') on the pack.
Weyfringe can help you to fulfil this requirement with our range of Easylabel software, thermal barcode label printers and 2D barcode verifiers.
Click here for more information